Use access key #2 to skip to page content.
$0.85 0.00 (-0.01%)
10/7/2008 3:45 PM

StemCells, Inc. (STEM)

CAPS Rating:
****

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

STEM doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

241 Outperforms
17 Underperforms
 

All-Stars

30 Outperforms
4 Underperforms
 

Members bullish on STEM are also bullish on:

Members bearish on STEM are also bearish on:

Ticker Tags

It's a Noun! (83), Micro Cap (4824), Biotechnology (295), Stem Cells (2)
Suggest a tag

StemCells, Inc. At A Glance

Current Price: $0.85
Last Trade Time: 10/7/2008 3:45 PM
Open: $0.00
Previous Close: $0.85
Daily Range: $0.83 - $0.98
52-Week Range: $0.67 - $2.44
Volume: 618,860
Market Cap: $68.76M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

STEM VS S&P 500 (SPY)

STEM 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for STEM

More Headlines...

Top Bull Pitch

Recs

4

StemCells, Inc. (STEM)

Avatar rpgcliff1 (59.58) Submitted: 2/20/08 7:20 PM

Any stem cell company will likely be big money makers in the future. As the cell products reach Phase III and go into the market these companies will be in a perfect position to make a lot of money. I personally prefer ASTM and GERN, but this company will do well in the future especially with suppor...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

StemCells, Inc. (STEM)

Avatar jelind43 (< 20) Submitted: 2/24/07 11:20 AM

No stem cell research company will do well until the Republicans are out of control.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 55 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (STEM)

Avatar maxy88 (98.82) Submitted: 5/04/08 8:47 PM : Outperform Start Price: $1.60 STEM Score: -17.79

This time the Democrats will win.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (STEM)

Avatar magnumbp (35.02) Submitted: 4/28/08 6:43 PM : Outperform Start Price: $1.57 STEM Score: -17.65

If the Dem's take 'the' office then this baby is going to sail!!! Either way it is cheap now and well worth the gamble.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (STEM)

Avatar fews (51.65) Submitted: 4/24/08 3:59 PM : Outperform Start Price: $1.62 STEM Score: -19.59

eventually stem cell will change the world. get it while it is low

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (STEM)

Avatar jfosu (< 20) Submitted: 4/24/08 1:42 PM : Underperform Start Price: $1.63 STEM Score: 19.82

This company receives a patent and jumps 20%? Tell me how that's going to make it any money in the next 10 years. There is only one drug in clinical trials and it's still far from phase III. The pipeline is weak and there's no product on the horizon that'll provide revenue for the company. Sorry, but there's no chance this stock is going anywhere from now until the new president is in office.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (STEM)

Avatar stratton6 (99.69) Submitted: 4/24/08 11:35 AM : Underperform Start Price: $1.75 STEM Score: 24.42

Products coming from stem cell research still have a long way to go before they will 1)become approvable by the FDA and 2) become a profitable entity for any company. There are some companies that have made impressive advances in stem cell research and it will become some day a very useful and profitable avenue for biotech. I don's think that STEM has the right management, the right tools or the right socio-political atmosphere (not just Bush) to make this happen within the next 5 years.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 55 :   1 2 3 4 5 Next » Jump to page:

Wall Street

There are no Wall Street tracker picks.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners